首页 > 最新文献

JU Open Plus最新文献

英文 中文
Editorial Comment: Effect of 3-Dimensional, Virtual Reality Models for Surgical Planning of Robotic Partial Nephrectomy on Surgical Outcomes: Qualitative Data from a Randomized Clinical Trial 编辑评论:用于机器人肾部分切除术手术规划的三维虚拟现实模型对手术结果的影响:来自随机临床试验的定性数据
Pub Date : 2024-02-01 DOI: 10.1097/ju9.0000000000000111
Nina Kar, Firas G. Petros
{"title":"Editorial Comment: Effect of 3-Dimensional, Virtual Reality Models for Surgical Planning of Robotic Partial Nephrectomy on Surgical Outcomes: Qualitative Data from a Randomized Clinical Trial","authors":"Nina Kar, Firas G. Petros","doi":"10.1097/ju9.0000000000000111","DOIUrl":"https://doi.org/10.1097/ju9.0000000000000111","url":null,"abstract":"","PeriodicalId":508272,"journal":{"name":"JU Open Plus","volume":"68 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139888230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Editorial Comment: Practice Patterns and Patient Experience of Care Among US Veterans with Prostate Cancer: A 10-Year Scoping Review 编辑评论:美国退伍军人前列腺癌患者的诊疗模式和护理体验:十年范围回顾
Pub Date : 2024-02-01 DOI: 10.1097/ju9.0000000000000116
Reno P. Maldonado, Granville L. Lloyd
{"title":"Editorial Comment: Practice Patterns and Patient Experience of Care Among US Veterans with Prostate Cancer: A 10-Year Scoping Review","authors":"Reno P. Maldonado, Granville L. Lloyd","doi":"10.1097/ju9.0000000000000116","DOIUrl":"https://doi.org/10.1097/ju9.0000000000000116","url":null,"abstract":"","PeriodicalId":508272,"journal":{"name":"JU Open Plus","volume":"30 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139877997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prone Split-Leg vs Galdakao-Modified Supine Valdivia Position During Endoscopic Combined Intrarenal Surgery: A Noninferiority Design Randomized Controlled Trial 内镜联合肾内手术中的俯卧分腿位与 Galdakao 改良仰卧瓦尔迪维亚位:非劣效性设计随机对照试验
Pub Date : 2024-02-01 DOI: 10.1097/ju9.0000000000000102
Teruaki Sugino, S. Hamamoto, K. Taguchi, Takaaki Inoue, S. Okada, T. Yanase, Yasuhito Sue, K. Kawase, R. Unno, R. Ando, A. Okada, T. Yasui
Endoscopic combined intrarenal surgery (ECIRS) combines percutaneous nephrolithotomy and ureteroscopy. This procedure has become common with the development of the prone split-leg (PRO) and Galdakao-modified supine Valdivia (GMSV) positions. In this study, we evaluated the surgical outcomes of these positions during ECIRS. A noninferior randomized controlled trial was performed in accordance with the Consolidated Standards of Reporting Trials. The eligibility criteria were age 20 to 80 years and presence of > 15-mm renal and/or ureteral stones. They were assigned to the PRO or GMSV groups and underwent ECIRS in the PRO or GMSV position, respectively. The primary outcome was stone-free rate (SFR) 3 months after surgery. The secondary outcomes were surgical outcomes—surgery time, percutaneous access time, and complication rate. A noninferiority margin of 30% was used. Eighty-six patients (46 in the PRO group and 43 in the GMSV group) were analyzed. The SFR was 91.3% and 90.7% in the PRO and GMSV groups, respectively. No between-group differences were observed regarding the overall complication rates. Percutaneous access time was longer in the PRO group than in the GMSV group for upper calyx punctures, whereas surgery and percutaneous access times were shorter in the PRO group for those with a middle calyx puncture. Surgical position did not affect the success rates. There was no difference in complications between the groups, except for perinephric hematoma formation.
内镜联合肾内手术(ECIRS)结合了经皮肾镜碎石术和输尿管镜检查。随着俯卧分腿式(PRO)和Galdakao-modified仰卧瓦尔迪维亚式(GMSV)体位的发展,这种手术已变得很常见。在本研究中,我们评估了 ECIRS 期间这些体位的手术效果。 根据《试验报告综合标准》,我们进行了一项非劣效随机对照试验。研究对象的资格标准是:年龄在20至80岁之间,肾结石和/或输尿管结石大于15毫米。他们被分配到PRO组或GMSV组,分别以PRO或GMSV体位接受ECIRS检查。主要结果是术后3个月的无结石率(SFR)。次要结果是手术结果--手术时间、经皮入路时间和并发症发生率。非劣效边际为 30%。 对 86 名患者(PRO 组 46 人,GMSV 组 43 人)进行了分析。PRO组和GMSV组的SFR分别为91.3%和90.7%。在总体并发症发生率方面,没有观察到组间差异。对于上萼穿刺,PRO 组的经皮穿刺时间长于 GMSV 组,而对于中萼穿刺,PRO 组的手术和经皮穿刺时间较短。 手术位置对成功率没有影响。除肾周血肿形成外,两组的并发症没有差异。
{"title":"Prone Split-Leg vs Galdakao-Modified Supine Valdivia Position During Endoscopic Combined Intrarenal Surgery: A Noninferiority Design Randomized Controlled Trial","authors":"Teruaki Sugino, S. Hamamoto, K. Taguchi, Takaaki Inoue, S. Okada, T. Yanase, Yasuhito Sue, K. Kawase, R. Unno, R. Ando, A. Okada, T. Yasui","doi":"10.1097/ju9.0000000000000102","DOIUrl":"https://doi.org/10.1097/ju9.0000000000000102","url":null,"abstract":"\u0000 \u0000 Endoscopic combined intrarenal surgery (ECIRS) combines percutaneous nephrolithotomy and ureteroscopy. This procedure has become common with the development of the prone split-leg (PRO) and Galdakao-modified supine Valdivia (GMSV) positions. In this study, we evaluated the surgical outcomes of these positions during ECIRS.\u0000 \u0000 \u0000 \u0000 A noninferior randomized controlled trial was performed in accordance with the Consolidated Standards of Reporting Trials. The eligibility criteria were age 20 to 80 years and presence of > 15-mm renal and/or ureteral stones. They were assigned to the PRO or GMSV groups and underwent ECIRS in the PRO or GMSV position, respectively. The primary outcome was stone-free rate (SFR) 3 months after surgery. The secondary outcomes were surgical outcomes—surgery time, percutaneous access time, and complication rate. A noninferiority margin of 30% was used.\u0000 \u0000 \u0000 \u0000 Eighty-six patients (46 in the PRO group and 43 in the GMSV group) were analyzed. The SFR was 91.3% and 90.7% in the PRO and GMSV groups, respectively. No between-group differences were observed regarding the overall complication rates. Percutaneous access time was longer in the PRO group than in the GMSV group for upper calyx punctures, whereas surgery and percutaneous access times were shorter in the PRO group for those with a middle calyx puncture.\u0000 \u0000 \u0000 \u0000 Surgical position did not affect the success rates. There was no difference in complications between the groups, except for perinephric hematoma formation.\u0000","PeriodicalId":508272,"journal":{"name":"JU Open Plus","volume":"46 24","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140464520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Saw Palmetto Treatment for Prostatitis: A Systematic Review of the Literature 锯棕榈治疗前列腺炎:文献系统回顾
Pub Date : 2024-02-01 DOI: 10.1097/ju9.0000000000000108
Ananth Punyala, C. Sze, Joshua Winograd, Alia Codelia-Anjum, Ernesto Morfin Montes de Oca, Naeem Bjohani, D. Elterman, K. Zorn, Bilal Chughtai
This systematic review was conducted to determine the safety and efficacy of Serenoa repens extract (saw palmetto extract) in treating chronic prostatitis, as compared with existing treatment regimens and placebo. Adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a systematic query was performed across multiple databases in December 2021 to identify relevant studies. The selection criteria focused on studies evaluating the treatment regimens, safety, and efficacy of saw palmetto in treating chronic prostatitis/chronic pelvic pain syndrome. Of 259 references, 21 studies encompassing 1666 patients were selected. These studies included a range of trial types, with a mean follow-up period of approximately 6.975 months. Saw palmetto extract showed improved symptom relief compared with placebo, with mixed results when compared with alpha-blockers or 5-ARIs. Multimodal treatments, especially those including saw palmetto extract alongside antibiotics, displayed better efficacy in managing both Category II and Category III prostatitis. Saw palmetto extract provides symptom relief in patients with chronic prostatitis. Although monotherapy exhibited certain benefits over placebo, its best efficacy was observed when integrated into multimodal treatment regimens, particularly with antibiotics for Category II prostatitis. Future research may unveil specific adjuncts that enhance the therapeutic outcomes of regimens containing saw palmetto extract.
本系统综述旨在确定锯棕榈提取物(Serenoa repens extract)治疗慢性前列腺炎的安全性和有效性,并与现有治疗方案和安慰剂进行比较。 根据系统综述和元分析首选报告项目(PRISMA)指南,2021 年 12 月在多个数据库中进行了系统查询,以确定相关研究。选择标准侧重于评估锯棕榈治疗慢性前列腺炎/慢性盆腔疼痛综合征的治疗方案、安全性和有效性的研究。 在 259 篇参考文献中,选取了 21 项研究,涉及 1666 名患者。这些研究包括各种试验类型,平均随访时间约为 6.975 个月。与安慰剂相比,锯棕榈提取物能更好地缓解症状;与α-受体阻滞剂或5-ARIs相比,结果不一。多模式疗法,尤其是将锯棕榈提取物与抗生素同时使用的疗法,在治疗 II 类和 III 类前列腺炎方面显示出更好的疗效。 锯棕榈提取物可缓解慢性前列腺炎患者的症状。虽然单药治疗比安慰剂有一定疗效,但将锯棕榈提取物纳入多模式治疗方案,尤其是与抗生素一起用于治疗第二类前列腺炎时,疗效最佳。未来的研究可能会揭示出一些特定的辅助疗法,以提高含有锯棕榈提取物的治疗方案的疗效。
{"title":"Saw Palmetto Treatment for Prostatitis: A Systematic Review of the Literature","authors":"Ananth Punyala, C. Sze, Joshua Winograd, Alia Codelia-Anjum, Ernesto Morfin Montes de Oca, Naeem Bjohani, D. Elterman, K. Zorn, Bilal Chughtai","doi":"10.1097/ju9.0000000000000108","DOIUrl":"https://doi.org/10.1097/ju9.0000000000000108","url":null,"abstract":"\u0000 \u0000 This systematic review was conducted to determine the safety and efficacy of Serenoa repens extract (saw palmetto extract) in treating chronic prostatitis, as compared with existing treatment regimens and placebo.\u0000 \u0000 \u0000 \u0000 Adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a systematic query was performed across multiple databases in December 2021 to identify relevant studies. The selection criteria focused on studies evaluating the treatment regimens, safety, and efficacy of saw palmetto in treating chronic prostatitis/chronic pelvic pain syndrome.\u0000 \u0000 \u0000 \u0000 Of 259 references, 21 studies encompassing 1666 patients were selected. These studies included a range of trial types, with a mean follow-up period of approximately 6.975 months. Saw palmetto extract showed improved symptom relief compared with placebo, with mixed results when compared with alpha-blockers or 5-ARIs. Multimodal treatments, especially those including saw palmetto extract alongside antibiotics, displayed better efficacy in managing both Category II and Category III prostatitis.\u0000 \u0000 \u0000 \u0000 Saw palmetto extract provides symptom relief in patients with chronic prostatitis. Although monotherapy exhibited certain benefits over placebo, its best efficacy was observed when integrated into multimodal treatment regimens, particularly with antibiotics for Category II prostatitis. Future research may unveil specific adjuncts that enhance the therapeutic outcomes of regimens containing saw palmetto extract.\u0000","PeriodicalId":508272,"journal":{"name":"JU Open Plus","volume":"116 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140463804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Editorial Comment: Effect of 3-Dimensional, Virtual Reality Models for Surgical Planning of Robotic Partial Nephrectomy on Surgical Outcomes: Qualitative Data from a Randomized Clinical Trial 编辑评论:用于机器人肾部分切除术手术规划的三维虚拟现实模型对手术结果的影响:来自随机临床试验的定性数据
Pub Date : 2024-02-01 DOI: 10.1097/ju9.0000000000000111
Nina Kar, Firas G. Petros
{"title":"Editorial Comment: Effect of 3-Dimensional, Virtual Reality Models for Surgical Planning of Robotic Partial Nephrectomy on Surgical Outcomes: Qualitative Data from a Randomized Clinical Trial","authors":"Nina Kar, Firas G. Petros","doi":"10.1097/ju9.0000000000000111","DOIUrl":"https://doi.org/10.1097/ju9.0000000000000111","url":null,"abstract":"","PeriodicalId":508272,"journal":{"name":"JU Open Plus","volume":"207 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139827946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Editorial Comment: Effect of 3-Dimensional, Virtual Reality Models for Surgical Planning of Robotic Partial Nephrectomy on Surgical Outcomes: Qualitative Data From a Randomized Clinical Trial 编辑评论:用于机器人肾部分切除术手术规划的三维虚拟现实模型对手术结果的影响:来自随机临床试验的定性数据
Pub Date : 2024-02-01 DOI: 10.1097/ju9.0000000000000110
Mikolaj Filon, Bogdana Schmidt
{"title":"Editorial Comment: Effect of 3-Dimensional, Virtual Reality Models for Surgical Planning of Robotic Partial Nephrectomy on Surgical Outcomes: Qualitative Data From a Randomized Clinical Trial","authors":"Mikolaj Filon, Bogdana Schmidt","doi":"10.1097/ju9.0000000000000110","DOIUrl":"https://doi.org/10.1097/ju9.0000000000000110","url":null,"abstract":"","PeriodicalId":508272,"journal":{"name":"JU Open Plus","volume":"108 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139829535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
From the Editor—January 2024 AUA Publications Committee Meeting 编辑的话--2024 年 1 月 AUA 出版委员会会议
Pub Date : 2024-02-01 DOI: 10.1097/ju9.0000000000000126
John W. Davis
{"title":"From the Editor—January 2024 AUA Publications Committee Meeting","authors":"John W. Davis","doi":"10.1097/ju9.0000000000000126","DOIUrl":"https://doi.org/10.1097/ju9.0000000000000126","url":null,"abstract":"","PeriodicalId":508272,"journal":{"name":"JU Open Plus","volume":"1058 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140467408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Comment: Prevalence, Incidence, and Determinants of Kidney Stones in a Nationally-representative Sample of US Adults 编辑评论:具有全国代表性的美国成年人样本中肾结石的流行率、发病率和决定因素
Pub Date : 2024-02-01 DOI: 10.1097/ju9.0000000000000117
Alfred Krebs, Mario I. Fernandez
{"title":"Editorial Comment: Prevalence, Incidence, and Determinants of Kidney Stones in a Nationally-representative Sample of US Adults","authors":"Alfred Krebs, Mario I. Fernandez","doi":"10.1097/ju9.0000000000000117","DOIUrl":"https://doi.org/10.1097/ju9.0000000000000117","url":null,"abstract":"","PeriodicalId":508272,"journal":{"name":"JU Open Plus","volume":"29 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139817940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to Editorial Comment: Effect of 3-Dimensional, Virtual Reality Models for Surgical Planning of Robotic Partial Nephrectomy on Surgical Outcomes: Qualitative Data from a Randomized Clinical Trial 回复社论评论:用于机器人肾部分切除术手术规划的三维虚拟现实模型对手术结果的影响:来自随机临床试验的定性数据
Pub Date : 2024-02-01 DOI: 10.1097/ju9.0000000000000120
Joseph D. Shirk
{"title":"Reply to Editorial Comment: Effect of 3-Dimensional, Virtual Reality Models for Surgical Planning of Robotic Partial Nephrectomy on Surgical Outcomes: Qualitative Data from a Randomized Clinical Trial","authors":"Joseph D. Shirk","doi":"10.1097/ju9.0000000000000120","DOIUrl":"https://doi.org/10.1097/ju9.0000000000000120","url":null,"abstract":"","PeriodicalId":508272,"journal":{"name":"JU Open Plus","volume":"42 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139821107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends in PubMed-Indexed Research in Matched Urology Applicants: A Cross-Sectional Analysis of the 2017 to 2021 Match Cycles 泌尿外科匹配申请人的 PubMed 索引研究趋势:2017 至 2021 年匹配周期的横断面分析
Pub Date : 2024-02-01 DOI: 10.1097/ju9.0000000000000103
D. Hinojosa-González, Shane Kronstedt, Gal Saffati, Nicholas Corsi, Anton Wintner, Dimitar V Zlatev, Wesley A. Mayer, Ruslan Korets, Brian H. Eisner
Urology is one of the most competitive specialties for residency matches in the United States. Data reported by the American Urological Association from match cycles spanning 2014 to 2021 reveal a median of 0.34% (0%-3%) of unfilled spots, a median of 1.48 (1.28-1.87) applicants per position, and a median of 75% (63%-87%) match rate. Recent research has shown that program directors value applicants' research highly. We sought to assess the research productivity of matched urology residency applicants, identify trends in research volume over time, and investigate the potential correlation between research output and program ranking. Doximity Urology program ranking list from the 2017 to 2021 match cycles was sorted by reputation, extracted, and populated using each program's official website resident roster, including name, medical school, postgraduate year, and additional degrees. Rosters were crossed-checked against social media posts from the official accounts. Each identified urology resident was queried in PubMed. Journal ranking was determined through Scimagojr; top-quartile journals were classified as Q1. In total 131 of 145 programs were identified, and 1605 matched applicants spanning the 2017 to 2021 match cycles. The mean and median total publications were 2.44 and 1, respectively, and 2.17 and 1 when excluding case reports. 64.2% of applicants had at least one publication, and 42.2% had at least one urological publication. Applicants matching into higher-ranked programs had more research and urological research. Multivariable regression analysis revealed that Q1 research (β 2.38) and urology research (β 2.33) significantly affected rank. Match cycle analysis revealed an increase in total and urology-focused research, whereas regression analysis demonstrated significant increases in total publications (β 0.019) per cycle. Overall research, urology-focused research, first authorship, and publication in higher-ranked journals play an essential role in the urology match.
泌尿外科是美国住院医师配对竞争最激烈的专业之一。美国泌尿外科协会报告的 2014 年至 2021 年匹配周期的数据显示,未填补名额的中位数为 0.34%(0%-3%),每个职位的申请人数中位数为 1.48(1.28-1.87)人,匹配率中位数为 75%(63%-87%)。最近的研究表明,项目主任非常重视申请人的研究成果。我们试图评估匹配的泌尿科住院医师申请者的研究成果,确定研究数量的长期趋势,并调查研究成果与项目排名之间的潜在相关性。 我们使用各项目官方网站上的住院医师名册,包括姓名、医学院、研究生年级和其他学位,对2017年至2021年匹配周期的Doximity泌尿外科项目排名表进行了声誉排序、提取和填充。名册与来自官方账户的社交媒体帖子进行交叉核对。在 PubMed 上查询了每位已确认的泌尿科住院医师。期刊排名通过 Scimagojr 确定;排名前四位的期刊被列为 Q1。 共确定了 145 个项目中的 131 个,2017 年至 2021 年匹配周期内有 1605 名匹配申请人。论文发表总数的平均值和中位数分别为 2.44 篇和 1 篇,如果不包括病例报告,则分别为 2.17 篇和 1 篇。64.2%的申请人至少发表过一篇论文,42.2%的申请人至少发表过一篇泌尿外科论文。与排名较高的项目匹配的申请人有更多的研究和泌尿科研究。多变量回归分析显示,第一季度研究(β 2.38)和泌尿科研究(β 2.33)对排名有显著影响。匹配周期分析表明,总研究和以泌尿外科为重点的研究有所增加,而回归分析表明,每个周期的论文总数有了显著增加(β 0.019)。 总体研究、以泌尿学为重点的研究、第一作者和在排名较高的期刊上发表论文在泌尿学匹配中发挥着重要作用。
{"title":"Trends in PubMed-Indexed Research in Matched Urology Applicants: A Cross-Sectional Analysis of the 2017 to 2021 Match Cycles","authors":"D. Hinojosa-González, Shane Kronstedt, Gal Saffati, Nicholas Corsi, Anton Wintner, Dimitar V Zlatev, Wesley A. Mayer, Ruslan Korets, Brian H. Eisner","doi":"10.1097/ju9.0000000000000103","DOIUrl":"https://doi.org/10.1097/ju9.0000000000000103","url":null,"abstract":"\u0000 \u0000 Urology is one of the most competitive specialties for residency matches in the United States. Data reported by the American Urological Association from match cycles spanning 2014 to 2021 reveal a median of 0.34% (0%-3%) of unfilled spots, a median of 1.48 (1.28-1.87) applicants per position, and a median of 75% (63%-87%) match rate. Recent research has shown that program directors value applicants' research highly. We sought to assess the research productivity of matched urology residency applicants, identify trends in research volume over time, and investigate the potential correlation between research output and program ranking.\u0000 \u0000 \u0000 \u0000 Doximity Urology program ranking list from the 2017 to 2021 match cycles was sorted by reputation, extracted, and populated using each program's official website resident roster, including name, medical school, postgraduate year, and additional degrees. Rosters were crossed-checked against social media posts from the official accounts. Each identified urology resident was queried in PubMed. Journal ranking was determined through Scimagojr; top-quartile journals were classified as Q1.\u0000 \u0000 \u0000 \u0000 In total 131 of 145 programs were identified, and 1605 matched applicants spanning the 2017 to 2021 match cycles. The mean and median total publications were 2.44 and 1, respectively, and 2.17 and 1 when excluding case reports. 64.2% of applicants had at least one publication, and 42.2% had at least one urological publication. Applicants matching into higher-ranked programs had more research and urological research. Multivariable regression analysis revealed that Q1 research (β 2.38) and urology research (β 2.33) significantly affected rank. Match cycle analysis revealed an increase in total and urology-focused research, whereas regression analysis demonstrated significant increases in total publications (β 0.019) per cycle.\u0000 \u0000 \u0000 \u0000 Overall research, urology-focused research, first authorship, and publication in higher-ranked journals play an essential role in the urology match.\u0000","PeriodicalId":508272,"journal":{"name":"JU Open Plus","volume":"369 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140468119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
期刊
JU Open Plus
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1